Nonpegylated liposomal doxorubicin combination regimen in patients with diffuse large B ‐cell lymphoma and cardiac comorbidity. Results of the HEART01 phase II trial conducted by the Fondazione Italiana Linfomi

Hematological Oncology,Volume 36, Issue 1, Page 68-75, February 2018.
Source: Hematological Oncology - Category: Hematology Source Type: research